4.3 Review

Blood Pressure: Return of the Sympathetics?

Journal

CURRENT HYPERTENSION REPORTS
Volume 18, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11906-015-0616-3

Keywords

Sympathetic nervous system; Hypertension; Sex; Aging; Chemoreceptors; Renal denervation; Cerebral blood flow

Funding

  1. Cibiem
  2. Medtronic
  3. Boston Scientific
  4. CVRX

Ask authors/readers for more resources

This brief review highlights new ideas about the role of the sympathetic nervous system in human blood pressure regulation. We emphasize how this role varies with age and sex and use our findings to raise questions about the sympathetic nervous system and hypertension in humans. We also focus on three additional areas, including (1) novel ideas about the carotid body and sympathoexcitation as it relates to hypertension, (2) clinical trials of renal denervation that attempted to treat hypertension by reducing ongoing sympathoexcitation, and (3) new ideas about resistant hypertension and cerebral blood flow. We further highlight that success of device-based therapy to modulate the sympathetic nervous system relies heavily on patient selection. Furthermore, data suggest that the majority of patients respond to anti-hypertensive therapy and the major cause of resistant hypertension is poor patient adherence. While the enthusiasm for device therapy or perhaps even precision medicine is high, it is likely that by far the most benefit to the most patients will occur via better screening, more aggressive therapy, and the development of strategies that improve patient adherence to medication regimens and lifestyle changes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available